STUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATION

Last updated: January 22, 2025
Sponsor: Eye Research Foundation, Inc.
Overall Status: Active - Recruiting

Phase

4

Condition

Blepharitis

Treatment

Moxidectin 2 MG Oral Tablet

Placebo

Clinical Study ID

NCT06795165
MOX-001
  • Ages > 18
  • All Genders

Study Summary

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Eligibility Criteria

Inclusion

Inclusion Criteria: Active blepharitis with collarettes -

Exclusion

Exclusion Criteria:Other clinically significant eye disease

Study Design

Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Moxidectin 2 MG Oral Tablet
Phase: 4
Study Start date:
February 15, 2025
Estimated Completion Date:
June 15, 2025

Connect with a study center

  • Eye Research Foundation, Inc.

    Newport Beach, California 92663
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.